Chronic tendonitis of triceps tendo

Reading File
Finding Sources
Finding Sources
Searching PubMed

triceps tendinopathy chronic treatment

Reading File
Finding Sources
Searching PubMed

tendinopathy chronic elbow treatment eccentric exercise

Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Searching the Web

chronic triceps tendinopathy clinical features diagnosis treatment 2024

Reading File
Reading Web Page

triceps tendinopathy chronic clinical features diagnosis treatment

I now have comprehensive information to provide a detailed answer. Let me compile it.

Chronic Tendinitis of the Triceps Tendon (Triceps Tendinopathy)

Overview

Chronic triceps tendinopathy is a degenerative condition of the distal triceps tendon, most commonly affecting the insertion on the olecranon. It is among the rarest elbow tendinopathies - triceps tendon ruptures account for less than 1% of all upper extremity tendon ruptures. The chronic form is best understood not as simple persistent inflammation, but as a failed tendon healing response - historically called "tendinitis," but now more accurately termed tendinopathy or tendinosis when degeneration predominates.

Anatomy

The triceps brachii has three heads (long, lateral, and medial) that converge into a single common tendon inserting onto the posterior surface of the olecranon. The distal tendon has a superficial and deep portion. Importantly, the area just proximal to the osseotendinous junction is relatively hypovascular, predisposing it to impaired healing and subsequent chronic tendinopathy.

Pathology

Histologically, chronic tendinopathy shows:
  • Collagen disorganization and fiber disruption
  • Angiofibroplastic hyperplasia (failed reparative response)
  • Increased microvasculature (neovascularization)
  • Sensory nerve ingrowth (explaining pain)
  • Dysregulation of extracellular matrix homeostasis
  • Possible calcification at the tendon insertion
This is fundamentally different from acute inflammation - there is minimal classic inflammatory infiltrate. The term "tendinitis" is thus a misnomer for established chronic disease.

Risk Factors & Aetiology

FactorDetail
Overuse / repetitive loadingWeightlifters, throwers, manual workers, bench press athletes
Sudden spike in training volumeEccentric loading during elbow extension activities
Anabolic steroid useWell-documented association
Multiple local corticosteroid injectionsWeakens tendon structure
Chronic olecranon bursitisAdjacent inflammatory process
Metabolic disordersDiabetes, endocrine disorders increase tendon vulnerability
GenderMore common in middle-aged males

Clinical Features

Symptoms:
  • Posterior elbow pain, typically at or just proximal to the olecranon, of gradual onset
  • Activity-related pain - worsened by pushing, dipping, pressing, or lifting with elbow extension
  • Pain with resisted elbow extension
  • Possible local swelling and tendon thickening
  • In severe cases, pain at rest
  • Weakness of elbow extension (though strength is usually maintained in pure tendinopathy without rupture)
Physical Examination:
  • Tenderness to palpation at the distal triceps insertion/olecranon
  • Pain reproduced by resisted elbow extension
  • Possible palpable tendon thickening
  • No palpable gap (distinguishes from complete rupture)
  • Full or near-full range of motion (unlike rupture)
Note: Approximately 50% of triceps tendon injuries are initially missed, so a high index of suspicion is needed.

Differential Diagnosis

  • Distal triceps tendon rupture (partial or complete)
  • Olecranon bursitis (can coexist)
  • Posterior elbow impingement
  • Radial nerve entrapment
  • Lateral or medial epicondylitis
  • Olecranon stress fracture
  • Posterior interosseous nerve compression

Investigations

Plain Radiographs (X-ray)

  • Often normal in pure tendinopathy
  • May show calcification at olecranon insertion (enthesopathy)
  • Rules out olecranon fracture

Ultrasound (US)

  • First-line imaging; dynamic, inexpensive
  • Chronic tendinopathy: tendon thickening, decreased echogenicity, collagen fiber disorganization, possible calcifications, poorly defined tendon margins
  • Power Doppler: increased vascularity (neovascularization) indicating chronic inflammation or reactive hyperemia
  • Can visualize both superficial and deep portions of the tendon insertion
  • Useful for guiding injections

MRI

  • Gold standard for tendon integrity assessment
  • Chronic tendinopathy: intermediate signal on T1, increased signal on T2 within tendon substance
  • Partial tears: small fluid-filled defect appearing bright on T2
  • Complete tears: large fluid-filled gap between tendon and olecranon
  • Best for pre-surgical planning

Management

Conservative (First-Line) - Minimum 12 months

1. Load Management
  • Relative rest; avoid provocative activities (heavy pressing, dipping) temporarily
  • Gradual return to activity
2. Physical Therapy - Progressive Tendon Loading (cornerstone)
  • Eccentric exercises and heavy slow resistance (HSR) training - most evidence-supported
  • Graded loading protocol: isometric → isotonic eccentric → plyometric
  • Shoulder-scapular stability work
  • Correction of technique/biomechanical faults
  • Manual therapy as adjunct for pain modulation and soft tissue mobility
3. NSAIDs
  • Short-term pain relief; not a long-term solution
  • Topical or oral (e.g., ibuprofen, naproxen)
  • Goldman-Cecil notes: "NSAIDs are often beneficial" alongside rest and modalities
4. Physical Modalities
  • Ice/cold application acutely
  • Heat, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT) - especially for chronic calcific tendinopathy
  • ESWT has emerging evidence for chronic insertional tendinopathy
5. Corticosteroid Injection
  • Used cautiously - may provide short-term relief but can weaken tendon tissue
  • Generally avoided in this location due to rupture risk; especially contraindicated with repeated injections
  • Goldman-Cecil: provides improvement for up to 8 weeks but "probably not long-term benefit"
6. Platelet-Rich Plasma (PRP)
  • Second-line injection option if simple conservative measures fail
  • Promotes healing of the degenerate tendon matrix
  • PMC evidence: PRP injection may be administered if activity modification, NSAIDs, and splinting fail
7. Splinting
  • Resting splint occasionally used in acute exacerbations to offload the tendon

Surgical Management

Indicated after minimum 12 months of failed conservative treatment.
Procedure:
  • Debridement of the affected (degenerate) tendon tissue
  • If significant structural damage: reconstruction/repair
  • For chronic ruptures (>6 weeks): tendon autograft or allograft augmentation (anconeus flap, Achilles rotation flap, plantaris tendon, hamstring tendon, or ligament augmentation devices)
  • Early postoperative mobilization to prevent stiffness
Postoperative Rehabilitation:
  • Immobilization in posterior splint at ~20° extension for 2 weeks
  • Passive range of motion weeks 2-6
  • Active extension initiated at 6 weeks
  • Strengthening at 10-12 weeks
  • Unrestricted activity at ~4 months

Prognosis

  • Chronic triceps tendinopathy responds well to graded rehabilitation when conservative measures are followed consistently
  • Strength recovery is less complete after chronic repair (>6 weeks) compared to acute repair
  • Outcome depends on duration of symptoms, degree of structural change, and adherence to rehabilitation

Key Summary

AspectKey Point
PathologyCollagen degeneration, neovascularization, failed healing (not pure inflammation)
PresentationPosterior elbow pain at olecranon, worse with resisted extension
ImagingUS (first-line), MRI (gold standard)
First-line treatmentLoad management + progressive loading/eccentric exercise
InjectionPRP preferred over corticosteroid for chronic disease
SurgeryDebridement ± reconstruction after 12 months failure of conservative care
Sources: Campbell's Operative Orthopaedics 15th Ed 2026; Miller's Review of Orthopaedics 9th Ed; Goldman-Cecil Medicine; Tendinopathies Around the Elbow (PMC4986646)
This is a shared conversation. Sign in to Orris to start your own chat.